Sayson, Edelito G.
HRN: 22-11-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/24/2022
10/31/2022
IV
600mg
IV
Non-healing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes